NCT02850029

An International Survey on Aminoglycoside Practices in Critically Ill Patients: AMINO III Survey

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 964 (actual)
• Sponsor: Centre Hospitalier Universitaire de Nīmes · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is an international observational cohort study on current aminoglycoside practices in intensive care units. Clinical and demographic data, dosing and therapeutic drug monitoring data will be collected during the first week of aminoglycoside (tobramycin, amikacin or gentamicin) administration in different countries over a year. A minimum of ten consecutive patients will be enrolled at each site.

Detailed description

Aminoglycosides are commonly used antibiotics for difficult to treat infections. However, aminoglycoside administration varies widely among countries. The aim of this multicenter observational study is to provide up-to-date and comprehensive descriptive data on current aminoglycoside (tobramycin, amikacin or gentamicin) use in a large cohort of critically ill patients in different countries. The benefits expected from this study are a better understanding of worldwide aminoglycoside prescription variability in critically ill patients and to determine the risk factors of inadequate aminoglycoside dosing regimens.

Conditions

• Underdosing of Aminoglycosides
• Critical Illness

Interventions

Type	Name	Description
OTHER	Observational study, no intervention

Timeline

• Start date: 2016-05-21
• Primary completion: 2017-12-31
• Completion: 2017-12-31
• First posted: 2016-07-29
• Last updated: 2025-11-21

Locations

85 sites across 5 countries: Australia, Chile, France, Greece, United Kingdom